Awardee OrganizationMASSACHUSETTS INSTITUTE OF TECHNOLOGY
Description
Abstract Text
Overall: PROJECT SUMMARY
Metastatic disease is responsible for the vast majority of cancer mortality. Understanding of the fundamental
mechanisms leading to metastatic cancer has been hampered by the need for models that replicate the step-
wise metastatic process in vivo, yet are amenable to tight control and facilitate high-resolution, time-lapse
imaging and quantitative analysis of cell behavior. Over the past decade, our team has developed in vivo and
in vitro methods capable of simulating many steps of the metastatic cascade including tumor cell invasion,
intravasation, trapping in the microcirculation or adhesion to the vessel walls, and extravasation into the
surrounding extracellular matrix. In parallel, we have developed computational studies that provided detailed
insights often not possible through experiments. This collective prior work has shed new light on central aspects
of single-cell and collective cell behavior during metastasis, and identified mechanical adaptations and
vulnerabilities of the tumor cell with promise for targeted interventions. The goal of our proposed U54 Center is
to employ these developed assays and methods in combination with new measurement techniques to interrogate
the full spectrum of stressors experienced by tumor cells in the metastatic niche during arrest and extravasation,
and couple these with parallel studies of changes in chromatin structure and the transcriptome of tumor cells
(Core B). These changes are critical to mechano-adaptation of the tumor cells towards an organ-preferential
initiation of a metastatic colony or transition to dormancy. A hallmark of our proposed center is the use of state-
of-the-art in vitro (Project 1) and in vivo (Project 2) experiments and computation (Core A) to uncover and probe
the factors that ultimately determine tumor cell fate. We anticipate that such integrated studies will provide new
insights into metastatic cancer, not possible by the use of any method alone, and enhance our ability to identify
and screen for new therapies to inhibit the tendency for metastatic spread of disease.
Public Health Relevance Statement
U54 CENTER: NARRATIVE
Metastatic organ colonization by circulating tumor cells depends on a response program in tumor cells,
termed mechano-adaptation, to cope with mechanical and molecular stresses. In this U54 MetNet Center,
we will integrate mechanical, genomic and ultrastructural information during metatastatic organ colonization
and identify mechanical mechanisms of tumor cell fate decisions and identify pathways and potential
therapeutic strategies to eliminate tumor cells prior to metastasis.
No Sub Projects information available for 5U54CA261694-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5U54CA261694-04
Patents
No Patents information available for 5U54CA261694-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5U54CA261694-04
Clinical Studies
No Clinical Studies information available for 5U54CA261694-04
News and More
Related News Releases
No news release information available for 5U54CA261694-04
History
No Historical information available for 5U54CA261694-04
Similar Projects
No Similar Projects information available for 5U54CA261694-04